Impact of immune-related adverse events on survival in patients with metastastic urothelial carcinoma treated with immune-checkpoint inhibitors.

被引：7
|
作者：
Morales-Barrera, Rafael
Suarez Rodriguez, Cristina
Gonzalez, Macarena
Ros, Javier
Eugenia Semidey, Maria
Hernandez, Ester Serra
Mateo, Joaquin
Saez, Carlos Fernandez
Lozano, Fernando
Mast, Richard
Roche, Sarai
Quintana, Angela
Gutierrez Fernandez, Sara
Serrano, Cesar
Valverde, Claudia
de Torres, Ines
Maldonado, Xavier
Morote, Juan
Carles, Joan
机构：
[1] Vall dHebron Inst, Barcelona, Spain
[2] Univ Autonoma Barcelona, Vall dHebron Inst Oncol, Barcelona, Spain
[3] Univ Autonoma Barcelona, Vall dHebron Inst Oncol, Vall dHebron Univ Hosp, Barcelona, Spain
[4] Vall dHebron Univ Hosp, Barcelona, Spain
[5] VHIO, Barcelona, Spain
[6] Vall dHebron Inst Oncol, Barcelona, Spain
[7] Vall dHebron Univ Hosp, Dept Pathol, Barcelona, Spain
[8] Vall dHebron Univ Hosp, Dept Urol, Barcelona, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.4531
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4531
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Predictive biomarkers for immune-related adverse events in cancer patients treated with immune-checkpoint inhibitors
    Jingting Wang
    Yan Ma
    Haishan Lin
    Jing Wang
    Bangwei Cao
    BMC Immunology, 25
  • [2] Predictive biomarkers for immune-related adverse events in cancer patients treated with immune-checkpoint inhibitors
    Wang, Jingting
    Ma, Yan
    Lin, Haishan
    Wang, Jing
    Cao, Bangwei
    BMC IMMUNOLOGY, 2024, 25 (01)
  • [3] Predictors of immune-related adverse events and outcomes in patients with NSCLC treated with immune-checkpoint inhibitors
    Serino, M.
    Freitas, C.
    Martins, M.
    Ferreira, P.
    Cardoso, C.
    Veiga, F.
    Santos, V.
    Araujo, D.
    Novais-Bastos, H.
    Magalhaes, A.
    Queiroga, H.
    Fernandes, G.
    Hespanhol, V.
    PULMONOLOGY, 2024, 30 (04): : 352 - 361
  • [4] Late immune-related adverse events with immune checkpoint inhibitors.
    Ip, Andrew
    Wang, Shuo
    Cheruku, Divya
    Krishnamurthy, Kanchi
    Weber, Melinda
    Sinclaire, Brittany
    Paleoudis, Elli Gourna
    Alaoui, Adil
    Lev-Ari, Shaked
    Serzan, Michael T.
    Adams, Shari
    Kaufman, Jordan
    Parikh, Sahil B.
    Tonti, Emily
    Muller, Eric
    Williams, Aquino
    Ahn, Jaeil
    Pecora, Andrew
    Atkins, Michael B.
    Shah, Neil J.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [5] Association of immune-related adverse events (irAEs) with clinical benefit in patients with metastatic urothelial carcinoma (mUC) treated with immune-checkpoint inhibitors (ICIs).
    Vitale, Nuzzo Pier
    Pond, Gregory Russell
    Abou Alaiwi, Sarah
    Nassar, Amin
    Flippot, Ronan
    Choueiri, Toni K.
    Harshman, Lauren Christine
    Sonpavde, Guru
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [6] Association of immune-related adverse effects and survival in responders treated with immune checkpoint inhibitors.
    Kapoor, Akhil
    Noronha, Vanita
    Patil, Vijay Maruti
    Joshi, Amit
    Menon, Nandini Sharrel
    Prabhash, Kumar
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [7] Immune-Related Adverse Events in Cancer Patients Treated With Immune Checkpoint Inhibitors
    Sandigursky, Sabina
    Mor, Adam
    CURRENT RHEUMATOLOGY REPORTS, 2018, 20 (10)
  • [8] Immune-Related Adverse Events in Cancer Patients Treated With Immune Checkpoint Inhibitors
    Sabina Sandigursky
    Adam Mor
    Current Rheumatology Reports, 2018, 20
  • [9] Immune-Related Adverse Events and Clinical Outcomes in Advanced Urothelial Cancer Patients Treated With Immune Checkpoint Inhibitors
    Sanda, Gregory E.
    Shabto, Julie M.
    Goyal, Subir
    Liu, Yuan
    Martini, Dylan J.
    Nazha, Bassel
    Brown, Jacqueline T.
    Yantorni, Lauren B.
    Russler, Greta Anne
    Caulfield, Sarah
    Joshi, Shreyas S.
    Narayan, Vikram M.
    Kissick, Haydn
    Ogan, Kenneth
    Master, Viraj A.
    Carthon, Bradley C.
    Kucuk, Omer
    Bilen, Mehmet Asim
    ONCOLOGIST, 2023, : 1072 - 1078
  • [10] Immune-Related Adverse Events and Survival Among Patients With Metastatic NSCLC Treated With Immune Checkpoint Inhibitors
    Cook, Sarah
    Samuel, Vanessa
    Meyers, Daniel E.
    Stukalin, Igor
    Litt, Ishjot
    Sangha, Randeep
    Morris, Don G.
    Heng, Daniel Y. C.
    Pabani, Aliyah
    Dean, Michelle
    Navani, Vishal
    JAMA NETWORK OPEN, 2024, 7 (01) : E2352302
12345